Blog

A $9 million grant to the University of California, Los Angeles aims to drive clinical trials for autism that would quickly rule out ineffective compounds.

On Saturday, the American Psychiatric Association released the DSM-5, the long-awaited new version of its Diagnostic and Statistical Manual of Mental Disorders.

The odds that the average new neuroscience study's findings are actually true are about 50-50, according to a report in the May Nature Reviews Neuroscience.

Little evidence supports the use of sign language for nonverbal children with autism, but other therapies show promise, says a review published 24 April in Frontiers in Integrative Neuroscience.

In April, Massachusetts-based diagnostics company SynapDx launched a large-scale study of its blood test for autism, which analyzes expression of a panel of genes.